Serbest 100mg Tablet
By Serbest
Rx
10 Tablet in a Strip

Composition
Sertraline(100mg)

Manufacturer - Sigmund Promedica
30-22-118, First Floor, Eluru Road,Seetharampuram,Vijayawada 520 002,Andhra Pradesh

Expires on or after
October, 2025

liver
When using Serbest 100mg Tablet, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment while taking Serbest 100mg Tablet, so it is crucial to consult your doctor before starting this medication. It is advised not to use Serbest 100mg Tablet in patients with severe liver disease to avoid any potential complications. Please follow your healthcare provider's guidance closely to ensure safe usage of this medication.

kidney
Serbest 100mg Tablet is safe for patients with kidney disease. No dose adjustment is necessary, but inform your doctor if you have kidney issues to possibly start with a lower dose, adjusting as needed.

alcohol
Caution Serbest 100mg Tablet can increase drowsiness when taken with alcohol. Avoid combining them.

driving
When taking Serbest 100mg Tablet, be aware that it may cause side effects that could impact your driving abilities. Pay attention to any symptoms that may impair your focus and reaction time while using this medication.

pregnancy
Serbest 100mg Tablet may not be safe to use during pregnancy. Animal studies indicate possible harmful effects on the baby's development. Your doctor will assess the benefits and risks before prescribing. Please consult your doctor.

breastfeeding
During breastfeeding, it is advised to avoid using Serbest 100mg Tablet as it may pass into breastmilk and harm the baby. Please consult your doctor before considering this medication.
Habit Forming | No |
Chemical Class | Tametraline Derivative |
Therapeutic Class | NEURO CNS |
Action Class | Selective Seretonin Reuptake inhibitors (SSRIs) |
₹101
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024